Empowering appropriate antimicrobial use with rapid diagnostics.

The Consequences

While achieving universal access to malaria diagnostic testing will not be easy, some countries have already shown that is can be done. In Senegal, following the introduction of malaria rapid diagnostic tests (RDTs) in 2007, malaria diagnostic testing rates rose rapidly from 4% to 86% (by 2009); the prescription of ACT dropped throughout this period from 73% of malaria-like febrile illness to 32%, reaching close equivalence to confirmed malaria (30% of 585,000 suspected fever cases). More than 500,000 courses of inappropriate ACT prescription were averted.1